/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced the promotion of Curran Simpson from Chief Technology and Operations Officer to Chief Operating.
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10,.
REGENXBIO Reports Update on Advancement of Programs for CLN2 Disease - read this article along with other careers information, tips and advice on BioSpace
REGENXBIO Inc. today announced a comprehensive program update to outline its progress and development plans for RGX-181 and RGX-381, both being developed as potential one-time gene therapies for the. | December 22, 2022
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced a comprehensive program update to outline its progress and development plans for RGX-181 and.